Northern Trust Corp I Teos Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 251,856 shares of ITOS stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

251,856

Previous 241,555 4.26%

Holding current value

$1.83 Million

Previous $3.58 Million 28.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.09 - $17.97 $103,937 - $185,108	10,301 Added 4.26%	251,856 $2.57 Million
Q2 2024 Aug 14, 2024	SELL	$10.33 - $18.09 $85,191 - $149,188	-8,247 Reduced 3.3%	241,555 $3.58 Million
Q1 2024 May 14, 2024	SELL	$9.89 - $13.64 $69,704 - $96,134	-7,048 Reduced 2.74%	249,802 $3.41 Million
Q4 2023 Feb 13, 2024	SELL	$8.57 - $11.06 $174,699 - $225,458	-20,385 Reduced 7.35%	256,850 $2.81 Million
Q3 2023 Nov 13, 2023	BUY	$10.95 - $14.6 $113,847 - $151,796	10,397 Added 3.9%	277,235 $3.04 Million
Q2 2023 Aug 11, 2023	BUY	$12.93 - $18.05 $191,609 - $267,482	14,819 Added 5.88%	266,838 $3.53 Million
Q1 2023 May 15, 2023	SELL	$13.02 - $22.62 $21,717 - $37,730	-1,668 Reduced 0.66%	252,019 $3.43 Million
Q4 2022 Feb 13, 2023	BUY	$17.77 - $21.6 $211,000 - $256,478	11,874 Added 4.91%	253,687 $4.95 Million
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $158,620 - $232,388	8,528 Added 3.66%	241,813 $4.61 Million
Q2 2022 Aug 12, 2022	BUY	$16.57 - $35.1 $586,594 - $1.24 Million	35,401 Added 17.89%	233,285 $4.81 Million
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $391,020 - $581,262	12,250 Added 6.6%	197,884 $6.37 Million
Q4 2021 Feb 08, 2022	BUY	$26.23 - $47.86 $241,001 - $439,737	9,188 Added 5.21%	185,634 $8.64 Million
Q3 2021 Nov 15, 2021	BUY	$23.91 - $29.58 $91,886 - $113,675	3,843 Added 2.23%	176,446 $4.76 Million
Q2 2021 Aug 13, 2021	SELL	$17.9 - $36.1 $359,897 - $725,826	-20,106 Reduced 10.43%	172,603 $4.43 Million
Q1 2021 May 12, 2021	BUY	$30.86 - $44.2 $1.88 Million - $2.69 Million	60,766 Added 46.05%	192,709 $6.59 Million
Q4 2020 Feb 11, 2021	BUY	$21.59 - $33.95 $92,383 - $145,272	4,279 Added 3.35%	131,943 $4.46 Million
Q3 2020 Nov 16, 2020	BUY	$17.57 - $32.92 $2.24 Million - $4.2 Million	127,664 New	127,664 $3.15 Million

Others Institutions Holding ITOS

# of Institutions

166

Shares Held

36.6M

Call Options Held

1.95M

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $258M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp I Teos Therapeutics, Inc. Transaction History